Xvivo Perfusion AB
STO:XVIVO

Watchlist Manager
Xvivo Perfusion AB Logo
Xvivo Perfusion AB
STO:XVIVO
Watchlist
Price: 453 SEK 0.11% Market Closed
Market Cap: 14.3B SEK
Have any thoughts about
Xvivo Perfusion AB?
Write Note

Xvivo Perfusion AB
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Xvivo Perfusion AB
Net Change in Cash Peer Comparison

Comparables:
O
OSSD
D
DOXA
BACTI B
V
VIMIAN
S
S2M

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Xvivo Perfusion AB
STO:XVIVO
Net Change in Cash
-kr144.3m
CAGR 3-Years
24%
CAGR 5-Years
-109%
CAGR 10-Years
N/A
O
OssDsign AB
STO:OSSD
Net Change in Cash
kr41.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
D
Doxa AB
STO:DOXA
Net Change in Cash
-kr141.5m
CAGR 3-Years
-178%
CAGR 5-Years
-60%
CAGR 10-Years
-51%
Bactiguard Holding AB
STO:BACTI B
Net Change in Cash
-kr74.5m
CAGR 3-Years
-79%
CAGR 5-Years
-50%
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Net Change in Cash
-€9.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
S2Medical AB (publ)
STO:S2M
Net Change in Cash
-kr290.2k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Xvivo Perfusion AB's Net Change in Cash?
Net Change in Cash
-144.3m SEK

Based on the financial report for Sep 30, 2024, Xvivo Perfusion AB's Net Change in Cash amounts to -144.3m SEK.

What is Xvivo Perfusion AB's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
-109%

The average annual Net Change in Cash growth rates for Xvivo Perfusion AB have been 24% over the past three years , -109% over the past five years .

Back to Top